RAN and cardiac hypertrophy: Lee and colleagues investigated the preventive function of RAN against monocrotaline-caused PAH in rat models and found that RAN attenuated ventricular hypertrophy, B-type natriuretic peptide values, fibrosis activation, and cardiovascular mortality [143].